Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moulés, V.
Right arrow Articles by Wattel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulés, V.
Right arrow Articles by Wattel, E.
[Cancer Research 65, 1234-1243, February 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

Fate of Premalignant Clones during the Asymptomatic Phase Preceding Lymphoid Malignancy

Vincent Moulés1, Carole Pomier1, David Sibon1,2, Anne-Sophie Gabet1, Michal Reichert3, Pierre Kerkhofs4, Luc Willems5, Franck Mortreux1 and Eric Wattel1,2

1 Oncovirologie et Biothérapies, UMR5537 CNRS-Université Claude Bernard, Centre Léon Bérard; 2 Service d'Hématologie, Pavillon E, Hôpital Edouard Herriot, Place d'Arsonval, Lyon, France; 3 Department of Pathology, National Veterinary Research Institute, Pulawy, Poland; 4 Department of Virology, Veterinary, and Agrochemical Research Centre, 1180 Uccle, Belgium; and 5 Faculté Universitaire des Sciences Agronomiques, Gembloux, Belgium

Requests for reprints: Eric Watel, Oncovirologie et Biothérapies, UMR5537 CNRS-Université Claude Bernard, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France. Phone: 33-4-78-78-26-69; Fax: 33-4-78-78-27-17; E-mail: wattel{at}lyon.fnclcc.fr.

Almost all cancers are preceded by a prolonged period of clinical latency during which a combination of cellular events helps move carcinogen-exposed cells towards a malignant phenotype. Hitherto, investigating the fate of premalignant cells in vivo remained strongly hampered by the fact that these cells are usually indistinguishable from their normal counterparts. Here, for the first time, we have designed a strategy able to reconstitute the replicative history of the bona fide premalignant clone in an animal model, the sheep experimentally infected with the lymphotropic bovine leukemia virus. We have shown that premalignant clones are early and clearly distinguished from other virus-exposed cells on the basis of their degree of clonal expansion and genetic instability. Detectable as early as 0.5 month after the beginning of virus exposure, premalignant cells displayed a two-step pattern of extensive clonal expansion together with a mutation load ~6 times higher than that of other virus-exposed cells that remained untransformed during the life span of investigated animals. There was no fixation of somatic mutations over time, suggesting that they regularly lead to cellular death, partly contributing to maintain a normal lymphocyte count during the prolonged premalignant stage. This equilibrium was finally broken after a period of 18.5 to 60 months of clinical latency, when a dramatic decrease in the genetic instability of premalignant cells coincided with a rapid increase in lymphocyte count and lymphoma onset.

Key Words: bovine leukemia virus • Leukemias and lymphomas • Animal models of cancer • Viral organisms and mechanisms • Retroviruses • Viral transformation and carcinogenesis




This article has been cited by other articles:


Home page
J. Virol.Home page
A. Florins, N. Gillet, M. Boxus, P. Kerkhofs, R. Kettmann, and L. Willems
Even Attenuated Bovine Leukemia Virus Proviruses Can Be Pathogenic in Sheep
J. Virol., September 15, 2007; 81(18): 10195 - 10200.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Debacq, N. Gillet, B. Asquith, M. T. Sanchez-Alcaraz, A. Florins, M. Boxus, I. Schwartz-Cornil, M. Bonneau, G. Jean, P. Kerkhofs, et al.
Peripheral Blood B-Cell Death Compensates for Excessive Proliferation in Lymphoid Tissues and Maintains Homeostasis in Bovine Leukemia Virus-Infected Sheep
J. Virol., October 1, 2006; 80(19): 9710 - 9719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.